Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting ...

BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...

Fintel reports that on November 18, 2024, BTIG initiated coverage of VYNE Therapeutics (NasdaqCM:VYNE) with a Buy ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

Digital Services Analyst Fuller holds a group dinner meeting with CFO Mahendra-Rajah and VP Subramanian in Florida on November 20 hosted by ...

On Thursday, Opendoor Technologies Inc (OPEN) stock saw a decline, ending the day at $1.77 which represents a decrease of $-0.04 or -2.21% from the prior close of $1.81. The stock opened at $1.81 and ...

"The bond market is telling you that Trump's policies will be inflationary and you're going to have tariffs, so the direction of the 10-year yield is going to be the indicator for how the small caps ...

Plug Power downgraded at BTIG Research, citing need for more product sales to boost margins in the hydrogen market.

On Tuesday, BTIG updated their assessment of Glaukos Corporation (NYSE:GKOS), increasing the price target to $140 from $139 while maintaining a Buy rating. This adjustment follows Glaukos' ...

On Monday, Dream Finders Homes Inc. (NYSE:DFH) shares maintained Neutral rating by BTIG, following a third-quarter earnings per share (EPS) that fell short of expectations. Dream Finders Homes ...